pharma news, views and analysis - pharmaphorum.com

Trending

in News
Risk of brain clots higher with COVID than vaccine, study suggests
April 16, 2021 Share
X
Risk of brain clots higher with COVID than vaccine, study suggests
https://pharmaphorum.com/news/risk-of-brain-clots-higher-with-covid-than-vaccine-study-suggests/
in News
Magic mushroom compound matches antidepressant in clinical trial
April 16, 2021 Share
X
Magic mushroom compound matches antidepressant in clinical trial
https://pharmaphorum.com/news/magic-mushroom-compound-matches-antidepressant-in-clinical-trial/

Latest News

Activist investor Elliott builds stake in GSK after fresh trial upset

Activist investor Elliott builds stake in GSK after fresh trial upset

Activist investor Elliott Management has built a significant stake in GlaxoSmithKline, after a poor run of clinical trial

X

Activist investor Elliott builds stake in GSK after fresh trial upset

https://pharmaphorum.com/news/activist-investor-elliott-builds-stake-in-gsk-after-fresh-trial-upset/

Evrysdi has ‘real world impact’ on lives of babies with severe SMA, says Roche

Evrysdi has ‘real world impact’ on lives of babies with severe SMA, says Roche

Roche’s Genentech unit has released further data from a key trial of Evrysdi, its oral treatment for spinal

X

Evrysdi has ‘real world impact’ on lives of babies with severe SMA, says Roche

https://pharmaphorum.com/news/evrysdi-has-real-world-impact-on-lives-of-babies-with-severe-sma-says-roche/

Romark eyes FDA okay for COVID antiviral despite mixed trial results

Romark eyes FDA okay for COVID antiviral despite mixed trial results

A phase 3 trial of Romark’s antiviral drug NT-300 has missed the main objective in a phase 3

X

Romark eyes FDA okay for COVID antiviral despite mixed trial results

https://pharmaphorum.com/news/romark-eyes-fda-okay-for-covid-antiviral-despite-mixed-trial-results/

Views & Analysis

The next generation of immunotherapy? Innate Pharma targets NK cells

The next generation of immunotherapy? Innate Pharma targets NK cells

Clinical-stage oncology biotech Innate Pharma is on a mission to harness the power of natural killer cells to

X

The next generation of immunotherapy? Innate Pharma targets NK cells

https://pharmaphorum.com/views-and-analysis/the-next-generation-of-immunotherapy-innate-pharma/

COVID heralds a faster future for drug development (if stakeholders can collaborate)

COVID heralds a faster future for drug development (if stakeholders can collaborate)

COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right

X

COVID heralds a faster future for drug development (if stakeholders can collaborate)

https://pharmaphorum.com/views-and-analysis/covid-heralds-a-faster-future-for-drug-development-if-stakeholders-can-work-together/

Jan van de Winkel: Building Europe’s biotech powerhouse at Genmab

Jan van de Winkel: Building Europe’s biotech powerhouse at Genmab

Jan van de Winkel has overseen one of biotech’s big success stories since he took over Genmab’s CEO

X

Jan van de Winkel: Building Europe’s biotech powerhouse at Genmab

https://pharmaphorum.com/views-and-analysis/jan-van-de-winkel-building-europes-biotech-powerhouse-at-genmab/

Debates & Insights

Customer engagement and pharma’s field force future

Customer engagement and pharma’s field force future

How healthcare professionals (HCPs) prefer to engage with pharma companies has been changing for some time, and COVID’s

X

Customer engagement and pharma’s field force future

https://pharmaphorum.com/webinars/axtria-customer-engagement-pharmas-field-force-future-digital-transformation/

AI, big data and deep real-world evidence – the challenges and opportunities

AI, big data and deep real-world evidence – the challenges and opportunities

Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights

X

AI, big data and deep real-world evidence – the challenges and opportunities

https://pharmaphorum.com/webinars/ai-big-data-real-world-evidence-savana/

Virtual trials and the next generation of pharma clinical research

Virtual trials and the next generation of pharma clinical research

Previously viewed as a ‘nice to have’ for the pharma industry, virtual trials were already moving from a

X

Virtual trials and the next generation of pharma clinical research

https://pharmaphorum.com/webinars/nihr-virtual-trials-pharma-research/

Partner Content

Cell-Mediated Therapies for Infectious Disease Summit

Cell-Mediated Therapies for Infectious Disease Summit

Cell-Mediated Therapies for Infectious Disease Summit

X

Cell-Mediated Therapies for Infectious Disease Summit

https://pharmaphorum.com/events/cell-mediated-therapies-for-infectious-disease-summit/

Induced Proximity-Based Drug Discovery Summit

Induced Proximity-Based Drug Discovery Summit

Induced Proximity-Based Drug Discovery Summit

X

Induced Proximity-Based Drug Discovery Summit

https://pharmaphorum.com/events/induced-proximity-based-drug-discovery-summit/

J+D FORECASTING MAKES THE PHARMA FORECASTING EXPERIENCE EVEN BETTER

J+D FORECASTING MAKES THE PHARMA FORECASTING EXPERIENCE EVEN BETTER

FC+, Pharma Forecasting Software has been upgraded

X

J+D FORECASTING MAKES THE PHARMA FORECASTING EXPERIENCE EVEN BETTER

https://pharmaphorum.com/partner-content/jd-forecasting-makes-the-pharma-forecasting-experience-even-better/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com